ERBB2 and ovarian carcinoma: Taken together, our results suggest that resveratrol and the derivatives, acetyl-resveratrol and polydatin, have antigrowth activities against 3D cell aggregates of ovarian cancer cell lines regardless of the level expression of EGFR and Her-2.